Latest
Sources
Trade Ideas
Speakers
Sign in
Go
Marvel Biosciences Secures Funding to Develop Child-Friendly Liquid Formulation for Neurodevelopmental Disorders
Original source ↗
| February 18, 2026 at 13:00 UTC |
Finnhub - MRVL
No analysis available.
Trade Ideas
Ticker
Direction
Speaker
Thesis
Time
MRVL
NONE
Finnhub News
—
—